Share on StockTwits
 

Chelsea Therapeutics International (NASDAQ:CHTP) was the recipient of some unusual options trading on Friday. Stock investors acquired 20,401 call options on the company, Stock Ratings News reports. This represents an increase of approximately 153% compared to the typical daily volume of 8,067 call options.

Several analysts have recently commented on the stock. Analysts at Roth Capital raised their price target on shares of Chelsea Therapeutics International to $7.00 in a research note on Friday, January 17th. Separately, analysts at Deutsche Bank raised their price target on shares of Chelsea Therapeutics International from $4.00 to $5.00 in a research note on Wednesday, January 15th. They now have a “hold” rating on the stock. Finally, analysts at Ladenburg Thalmann raised their price target on shares of Chelsea Therapeutics International to $7.00 in a research note on Wednesday, January 15th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $7.00.

Shares of Chelsea Therapeutics International (NASDAQ:CHTP) traded down 4.25% on Friday, hitting $4.73. The stock had a trading volume of 20,890,588 shares. Chelsea Therapeutics International has a 52-week low of $0.76 and a 52-week high of $5.78. The stock’s 50-day moving average is $4. and its 200-day moving average is $3.. The company’s market cap is $334.7 million.

Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.